South and Central America Cryoablation Market (2022-2033)

The South and Central America cryoablation market size is expected to reach US$ 99.6 million by 2033 from US$ 58.6 million in 2025. The market is estimated to record a CAGR of 6.6% from 2026 to 2033.

Executive Summary and South and Central America Cryoablation Market Analysis:

The South and Central America cryoablation market is gradually expanding as healthcare providers increasingly adopt minimally invasive treatment approaches for cardiac and oncologic conditions. Cryoablation is gaining attention for its precision, tissue-sparing benefits, and ability to reduce recovery time, making it an appealing alternative to traditional surgical interventions. Market growth is supported by the modernization of specialized cardiac and oncology centers, rising clinician awareness of interventional technologies, and growing patient interest in less invasive therapies. Urban hospitals and tertiary care centers are at the forefront of adoption, offering advanced imaging and catheterization capabilities that enable safe and effective procedural implementation.

Despite these positive trends, the market faces constraints that impact adoption across the region. Limited availability of trained interventional specialists in rural areas, variations in hospital infrastructure, and inconsistent reimbursement policies can hinder procedural accessibility. Competition from established ablation modalities, such as radiofrequency and microwave therapies, also affects clinician preference. However, ongoing initiatives to expand professional training, improve procedural infrastructure, and collaborate with global device manufacturers are gradually addressing these challenges. These efforts, combined with rising patient awareness, are fostering a favorable environment for the expansion of cryoablation services across South and Central America.

South and Central America Cryoablation Market - Strategic Insights:

South and Central America Cryoablation Market Segmentation Analysis:

Key segments that contributed to the derivation of the South and Central America cryoablation market analysis are product type, application, and end user.

• By product type, the cryoablation market is segmented into cryoablation systems, ablation probes and catheters, and consumables & accessories. The ablation probe and catheter segment dominated the market in 2025.
• Based on application, the cryoablation market is classified into cardiology, oncology, pain management, and other applications. The oncology segment dominated the market in 2025.
• In terms of end user, the cryoablation market is categorized into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment dominated the market in 2025.

South and Central America Cryoablation Market Drivers and Opportunities:

Surge in Chronic Disease Rates Observed

The South and Central America region is experiencing a noticeable rise in chronic illnesses that is shaping demand for advanced therapeutic solutions like cryoablation. Cardiovascular conditions such as arrhythmias and complex structural heart issues are increasingly seen in clinical practice across major markets like Brazil, Argentina, and Mexico. Leading cardiology centers in these countries are integrating minimally invasive procedures, including cryoablation, into their treatment pathways to address patient needs with reduced procedural risk and recovery time.

Cancer care in the region is also evolving, as oncology specialists look for localized treatment options that complement systemic therapies. Cryoablation is gaining interest in oncology clinics and interventional radiology departments for managing selected solid tumors, especially where preserving surrounding healthy tissue is a priority. Hospitals that serve metropolitan populations are incorporating cryoablation into their service mix to offer a broader range of options for patients who may not be ideal candidates for surgery.

In addition to heart and cancer care, aging populations and growing prevalence of metabolic conditions are increasing the overall procedural workload for tertiary care facilities. Providers are strengthening their chronic disease management programs and investing in technologies that can serve multiple specialties. As clinicians become more familiar with the clinical advantages of cryoablation, referrals for these procedures are rising, reinforcing the role of cryoablation in comprehensive treatment strategies across the region.

Exploring New Clinical Use Cases

Cryoablation in South and Central America is moving beyond its established applications and being explored for an expanding set of clinical indications. Pain management is emerging as an area of interest, with interventional pain clinics and multidisciplinary care teams evaluating cryoablation for targeted relief in patients with chronic or localized pain that has been difficult to manage with conventional therapies. This helps meet growing patient demand for minimally invasive options that can offer meaningful symptom control.

Structural and soft‑tissue procedures are another avenue where cryoablation is gaining traction. Hospitals with advanced imaging capabilities in cities such as São Paulo, Buenos Aires, and Santiago are incorporating cryoablation into care pathways for benign lesions and other localized conditions. These applications allow clinicians to treat challenging cases without resorting to more invasive surgery, aligning with broader institutional goals of reducing hospital stays and improving patient comfort.

Collaborations between device manufacturers and regional healthcare institutions are also supporting adoption in new clinical areas. Through training programs, procedural workshops, and shared clinical guidance, practitioners are building confidence in applying cryoablation techniques across a broader spectrum of indications—from pain and soft‑tissue interventions to emerging uses in specialty clinics. This collaborative ecosystem is strengthening cryoablation’s reputation as a flexible, versatile therapy throughout South and Central America.

South and Central America Cryoablation Market Size and Share Analysis:

The South and Central America cryoablation market demonstrates steady growth, with size and share analysis highlighting evolving trends and competitive dynamics among key players. The report evaluates important subsegments categorized within product type, application, and end user, highlighting their respective contributions to overall market performance.

By product type, the ablation probe and catheter subsegment dominated the market in 2025. This is driven by the recurring need for precise and reliable probes and catheters during cryoablation procedures, essential for effective freezing and destruction of targeted tissues, making them a key revenue driver for manufacturers and ensuring consistent demand in clinical settings.

In terms of application, the oncology subsegment dominated the market in 2025. The leadership of oncology applications is attributed to the rising incidence of cancer cases, growing preference for minimally invasive tumor ablation techniques, and increasing awareness among healthcare providers about the effectiveness of cryoablation in treating liver, kidney, prostate, and other solid tumors.

Based on end user, the hospitals subsegment dominated the market in 2025. Hospitals maintain a stronghold due to their well-established oncology and surgical departments, access to advanced cryoablation equipment, trained interventional radiologists and staff, and the capability to perform complex procedures with comprehensive patient care.

South and Central America Cryoablation Market Report Highlights:

South and Central America Cryoablation Market Report Coverage and Deliverables:

The "South and Central America Cryoablation Market Size and Forecast (2022–2033)" report provides a detailed analysis of the market covering below areas:

• South and Central America Cryoablation market size and forecast at regional and country levels for all market segments covered under the scope
• South and Central America Cryoablation market trends, as well as drivers, restraints, and opportunities
• South and Central America Cryoablation market analysis covering key trends, regional framework, major players, regulations, and recent developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the South and Central America Cryoablation market
• Detailed company profiles, including SWOT analysis

South and Central America Cryoablation Market Geographic Insights:

The geographical scope of the South and Central America cryoablation market report is divided into: Brazil, Argentina, Chile, Colombia, Peru, and the Rest of South and Central America. Brazil held the largest share in 2025.

Brazil dominates the South and Central America cryoablation market due to its advanced healthcare infrastructure, concentration of specialized hospitals, and focus on clinical innovation. Leading cardiac and oncology centers in major cities have integrated cryoablation into standard treatment protocols for complex arrhythmias and select tumor indications, supported by modern catheterization laboratories and imaging facilities. The country benefits from structured clinician training programs and collaboration with international medical device providers, which strengthens procedural expertise and confidence in cryoablation adoption. Multidisciplinary care teams, including electrophysiologists, interventional radiologists, and oncologists, ensure precise patient selection and optimal treatment outcomes. Patient awareness of minimally invasive therapies has increased demand, encouraging hospitals to expand service availability and invest in high-tech interventional suites. While regional disparities exist between urban and rural healthcare facilities, Brazil’s focus on healthcare modernization, technology adoption, and clinical excellence continues to reinforce its leadership in the South and Central America cryoablation market.

South and Central America Cryoablation Market Research Report Guidance:

• The report includes qualitative and quantitative data in the South and Central America Cryoablation market across product type, application, end user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the South and Central America Cryoablation market.
• Chapter 3 focuses on the research methodology of the study.
• Chapter 4 includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the South and Central America Cryoablation market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the South and Central America Cryoablation market scenario, in terms of historical market revenues, and forecast till the year 2033.
• Chapters 7 to 10 cover South and Central America Cryoablation market segments by product type, application, end user, and geography across Brazil, Argentina, Chile, Colombia, Peru, and the Rest of South and Central America. They cover the market revenue, forecast, and factors driving the market.
• Chapter 11 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 12 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 13 provides detailed profiles of the major companies operating in the South and Central America Cryoablation market. Companies have been profiled on the basis of their key facts, business descriptions, products, financial overview, SWOT analysis, and key developments.
• Chapter 14, i.e., the appendix, is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

South and Central America Cryoablation Market News and Key Development:

The South and Central America cryoablation market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the South and Central America cryoablation market are:

• In April 2024, IceCure Medical Ltd. reported full‑year 2023 financial results noting that following regulatory approval in Brazil, commercial activities have commenced through its in‑country distributor and that procedures using the ProSense system are underway as part of its continued expansion into the Brazilian cryoablation market.
• In June 2022, IceCure Medical Ltd. announced that its distributor in Brazil, KTRFIOS Importaçao e Exportaçao Ltda., had submitted a regulatory filing to the Brazilian Health Regulatory Agency (ANVISA) for approval of the company’s ProSense cryoablation system across multiple oncological indications, marking a key step toward formal market entry in South America’s largest healthcare market.

Key Sources Referred:

• The World Bank
• World Health Organization (WHO)
• Center for Disease Control and Prevention (CDC)
• Food and Drug Administration (FDA)
• European Database on Medical Devices (EUDAMED)
• European Society of Cardiology (ESC)
• American College of Cardiology (ACC)
• American Heart Association (AHA)
• Company Websites
• Company Annual Reports
• Company Investor Presentations